Skip to main content

Stanton Marshall S.

In the past year, 7 open-market sale filings worth $3.43M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$3.43M
7 filings
Net
−$3.43M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Stanton Marshall S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 4, 2026 (view filing)Mar 31 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−2.15K$37.78−$81.2K−3.5%60.1K after
Mar 3, 2026 (view filing)Mar 21 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−1.51K$38.02−$57.5K−3.6%40.4K after
Feb 25, 2026 (view filing)Feb 23-242 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−3.68K$36.94−$136.0K−8.1%41.9K after2 lots
Nov 24, 2025 (view filing)Nov 213 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−47.4K$45.04−$2.13M−51.4%44.8K after4 lots
Nov 24, 2025 (view filing)Nov 204 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−15.3K$44.18−$674.8K−25.4%44.8K after3 lots
Nov 14, 2025 (view filing)Nov 131 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−4.99K$45.86−$229.0K−8.1%56.6K after
Nov 12, 2025 (view filing)Nov 102 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−2.57K$44.62−$114.5K−4.0%61.6K after
Aug 28, 2025 (view filing)Aug 271 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−18.2K$44.02−$801.2K−22.1%64.2K after
Jun 18, 2025 (view filing)Jun 171 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−15.0K$29.50−$442.5K−18.9%64.2K after2 lots10b5-1
Jun 16, 2025 (view filing)Jun 133 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−26.1K$28.44−$743.1K−24.8%79.2K after4 lots10b5-1
May 12, 2025 (view filing)May 93 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−10.5K$29.13−$307.3K−9.1%105.3K after2 lots
Mar 10, 2025 (view filing)Mar 64 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−1.60K$24.80−$39.8K−1.4%115.9K after
Feb 26, 2025 (view filing)Feb 242 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−4.69K$27.31−$128.0K−5.5%79.8K after4 lots
Mar 21, 2024 (view filing)Mar 201 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−2.18K$20.39−$44.5K−2.6%83.3K after
Mar 14, 2024 (view filing)Feb 2617 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−3.01K$20.27−$61.0K−3.5%81.7K afterAmended2 lots
Mar 14, 2024 (view filing)Feb 2716 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−465$19.83−$9.22K−0.6%81.3K afterAmended
Mar 14, 2024 (view filing)Mar 113 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−1.51K$18.72−$28.2K−1.7%85.5K afterAmended
Mar 3, 2023 (view filing)Mar 21 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−907$13.41−$12.2K−1.7%52.1K after
Mar 1, 2023 (view filing)Feb 272 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−2.34K$12.94−$30.2K−4.5%49.3K after2 lots